HIV, Equity, and Addiction Training (HEAT) Program

Hiv Clinical Trial

— HEAT  

Official title:

HIV, Equity, and Addiction Training (HEAT) Program

Clinical Trial Details — Status: Not yet recruiting

Administrative data

• NCT number: NCT06370481
• Other study ID #: IRB-300012349
• Status: Not yet recruiting
• Phase: N/A
• Start date: June 2024
• Est. completion date: December 2029

Study information

• Verified date: April 2024
• Source: University of Alabama at Birmingham
• Contact: Ellen F Eaton, MD, MSPH
• Phone: 2059750661
• Email: eeaton[@]uabmc.edu
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

This project is a pilot study to determine the feasibility and acceptability of a telemedicine intervention for substance use disorder service delivery in diverse people living with HIV in Alabama.

Description:

The contemporary drug crisis and the COVID-19 pandemic have exposed the complex syndemics of addiction and infectious diseases: rising rates of substance use disorder (SUD) have outpaced our ability to respond with a limited healthcare workforce and public health capacity. SUD is increasing in those living with and at risk for HIV, and infectious consequences of SUD, like hepatitis C, have continued, unmitigated, in rural parts of the U.S. where many states lack Medicaid expansion, syringe service programs, and public health infrastructure to respond to the drug crisis and comorbid infections. Systemic racism and regressive policies in the Deep South criminalize people who use drugs, creating additional barriers to care, HIV prevention, and addiction treatment. As a result, people who use drugs rarely receive comprehensive addiction and HIV treatment. Yet telemedicine has the potential to overcome these barriers and bypass the constraints of a brick-and-mortar clinic to link vulnerable people, including those with HIV, to care. Although telemedicine has become mainstream in recent years, few studies have evaluated telemedicine for SUD in the Deep South from the perspective of patients and providers.

Recruitment information / eligibility

• Status: Not yet recruiting
• Enrollment: 30
• Est. completion date: December 2029
• Est. primary completion date: June 2029
• Accepts healthy volunteers: No
• Gender: All
• Age group: 18 Years and older

Eligibility

Inclusion Criteria:

• Receiving services at HIV clinics in Alabama

• Reported opioid and/or stimulant misuse

• 18 years of age or older

Exclusion Criteria:

• Receipt of SUD clinical care other than through HIV provider/clinic in the last 3 months

• Inability to engage in interviews independently without support (e.g., cognitive impairment)

• Currently psychotic

• Actively suicidal: presents with a suicide attempt or suicidal ideation

Related Conditions & MeSH terms

• Hiv
• Opioid Use Disorder
• Opioid-Related Disorders
• Substance Use Disorders
• Substance-Related Disorders

Intervention

Other:
• Telemedicine
Routine care administered via telemedicine
• Standard of care
Standard of care, as received in HIV clinic settings

Locations

Country	Name	City	State
United States	University of Alabama at Birmingham	Birmingham	Alabama

Sponsors (1)

Lead Sponsor	Collaborator
University of Alabama at Birmingham

Country where clinical trial is conducted

United States, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Percent of participants who have a follow-up healthcare visit	Follow up visit for care (either telemedicine or in person)	1 month, 2 months, 3 months